rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Timothy Wright

Director

Company insider

Files Form 4 as: Director, Agenus.

Every Form 4 they filed

In numbers

Trades disclosed
113
Buys
1
Sells
0
Bought
$13K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
7 Jun 2007
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
AGEN AgenusDirector · Biotechnology · last 1 Oct 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—1,178.764filing
5 Aug 2026filed 7 Aug 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
5 Aug 2026filed 7 Aug 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
1 Jul 2026filed 7 Jul 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,267.765filing
1 Jul 2026filed 7 Jul 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,267.77filing
24 Apr 2026filed 28 Apr 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—105,000 at $0.00filing
24 Apr 2026filed 28 Apr 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—105,000 at $0.00filing
1 Apr 2026filed 2 Apr 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,448.256filing
1 Apr 2026filed 2 Apr 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,448.26filing
2 Jan 2026filed 5 Jan 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,040.576filing
2 Jan 2026filed 5 Jan 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,040.58filing
1 Oct 2025filed 3 Oct 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—1,704.93filing
1 Jul 2025filed 3 Jul 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,707.83filing
17 Jun 2025filed 20 Jun 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—750 at $0.00filing
17 Jun 2025filed 20 Jun 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
1 Apr 2025filed 2 Apr 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—3,255.59filing
2 Jan 2025filed 2 Jan 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—2,532.66filing
1 Oct 2024filed 3 Oct 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—1,252.49filing
1 Jul 2024filed 1 Jul 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—776.02filing
11 Jun 2024filed 18 Jun 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—750 at $0.00filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Thomas L. HarrisonDirector · Director at Agenus, filing Form 4 there in the last year
Marco Tullio MarcucciDirector · Director at Agenus, filing Form 4 there in the last year
Garo H. ArmenExec. Chair & Principal Off · Director and Officer at Agenus, filing Form 4 there in the last year
Brian CorveseDirector · Director at Agenus, filing Form 4 there in the last year
Jennifer BuellChief Executive Officer · Director and Officer at Agenus, filing Form 4 there in the last year